Adhera Therapeutics, Inc. (ATRX) financial statements (2022 and earlier)

Company profile

Business Address P.O. BOX 2161
WAKE FOREST, NC 27588
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 11003,918106105710
Cash and cash equivalents 11003,918106105710
Receivables   48   
Inventory, net of allowances, customer advances and progress billings   241   
Inventory   241   
Prepaid expense  275179  114
Other current assets      26
Other undisclosed current assets  4529019211 
Total current assets: 14204,677125316850
Noncurrent Assets
Property, plant and equipment   72   
Intangible assets, net (including goodwill)   3926,0595,8706,700
Goodwill    3,5033,558 
Intangible assets, net (excluding goodwill)   3922,5562,3126,700
Other noncurrent assets      45
Total noncurrent assets:   4646,0595,8706,745
TOTAL ASSETS: 14205,1416,1846,1867,595
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 8,4524,9732,1862,1732,0572,436
Accounts payable 2,2571,4032701,033663763
Accrued liabilities 2,1121,0058521,1391,3941,296
Employee-related liabilities      377
Interest and dividends payable 4,0832,5651,064   
Debt 6,3185,330 444436 
Due to related parties 44281,33783 
Other undisclosed current liabilities    1,782392 
Total current liabilities: 14,77410,3072,2145,7362,9682,436
Noncurrent Liabilities
Liabilities, other than long-term debt      2,345
Deferred tax liabilities, net   2,345
Other undisclosed noncurrent liabilities      2,551
Total noncurrent liabilities:      4,896
Total liabilities: 14,77410,3072,2145,7362,9687,332
Stockholders' equity
Stockholders' equity attributable to parent, including: (14,773)(9,887)2,9274483,219263
Common stock 67656563539 
Additional paid in capital 29,77229,37528,7108,4144,631334,548
Accumulated deficit (44,612)(39,327)(25,848)(8,029)(1,951)(334,451)
Other undisclosed stockholders' equity attributable to parent   0  166
Total stockholders' equity: (14,773)(9,887)2,9274483,219263
TOTAL LIABILITIES AND EQUITY: 14205,1416,1846,1867,595

Income statement (P&L) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues  25276  680
Revenue, net  680
Cost of revenue
(Cost of Goods and Services Sold)
  (409)(459)   
Gross profit:  (157)(383)  680
Operating expenses (2,037)(11,159)(15,412)(6,091)(758)(4,669)
Operating loss: (2,037)(11,316)(15,795)(6,091)(758)(3,989)
Nonoperating income (expense) 45 (960)(128)(79)7,326
Other nonoperating income 45     
Interest and debt expense (1,774)(682)(810)(79)(4) 
Income (loss) from continuing operations before equity method investments, income taxes: (3,766)(11,998)(17,565)(6,297)(840)3,337
Other undisclosed income from continuing operations before income taxes  20810794 
Income (loss) from continuing operations before income taxes: (3,766)(11,978)(16,755)(6,219)(836)3,337
Income tax expense    (1)(1) 
Net income (loss) attributable to parent: (3,766)(11,978)(16,755)(6,219)(837)3,337
Preferred stock dividends and other adjustments (1,540)(1,501)(1,064)   
Other undisclosed net loss available to common stockholders, basic      (690)
Net income (loss) available to common stockholders, diluted: (5,306)(13,479)(17,819)(6,219)(837)2,647

Comprehensive Income ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss): (3,766)(11,978)(16,755)(6,219)(837)3,337
Comprehensive income (loss), net of tax, attributable to parent: (3,766)(11,978)(16,755)(6,219)(837)3,337

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: